Horizon: The EU Research & Innovation Magazine

Oncology & Cancer

Breast cancer: An aggressive variant triggers a hunt for cures

Triple negative breast cancer is a hard-to-treat form that accounts for 15% of all cases, with recovery hopes emerging from chemotherapy drugs that stimulate the immune system and others that cause tumor cells to implode.

page 5 from 21